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The effect of passage in vitro and in vivo on the
properties of murine fibrosarcomas.
II. Sensitivity to cell-mediated cytotoxicity in vitro
M.F.A. Woodruff and B.A. Hodson
Medical Research Council Clinical and Population Cytogenetics Unit, Western General Hospital, Crewe Road,
Edinburgh EH4 2XU, UK
Summary The sensitivity of cultured and mouse-passaged cloned lines of chemically-induced murine
fibrosarcomas to killing by NK and NC cells, and to cell-mediated immunity, has been studied in in vitro
assays, using target cells labelled with 51Cr or 125IUDR. None of the lines tested proved sensitive to NK
cells. Three cultured lines were, at most, only slightly sensitive to NC cells; a fourth cultured line was
moderately sensitive and became less so, but not completely insensitive, after passage in susceptible hosts. The
primary object of these experiments was to test the hypothesis that cultured cell lines which ordinarily fail to
grow in normal mice are able to grow after being passaged in a susceptible immunodeficient host because,
during this passage, they become resistant to NK or NC cells. This has been shown to occur with one clone,
but will not serve as a general explanation because, with other clones, both cultured and mouse-passaged lines
were NC-insensitive. The cell-mediated immunity assays confirm our previous conclusion that cultured and
mouse-passaged lines ofthe same clone differ little, ifit all, in immunogenicity.
In the preceding paper (Woodruff & Hodson, 1985)
we reported that cloned cell lines of strongly
immunogenic chemically-induced murine fibro-
sarcomas maintained in tissue culture usually fail
to grow when transplanted to normal mice,
whereas they grow readily in various categories of
T-cell deficient mice and after such passage grow
readily in normal mice. We suggested three possible
explanations which might account for these
findings: (i) Emergence during the initial passage of
tumour cells resistant to effector cells which exhibit
cytotoxicity that is non-acquired, i.e. not contingent
on previous specific priming or non-specific
activation of some kind. Following Stutman et al.
(1978) we have used the label NK for cells of this
kind which kill in short term (4h) in vitro assays
and NC for those whose activity is shown only in
more prolonged (15-24h) assays. (ii) Acquisition
during the initial passage of a protective surface
molecule that interferes with the efferent side of the
immune response when the tumour is subsequently
transplanted to a normal host. (iii) Loss during the
initial passage of a Class I MHC molecule
necessary for dual recognition of the tumour cells
by T cells when they are transplanted to a normal
host.
We now report observations on the sensitivity of
cultured and mouse-passaged cloned fibrosarcoma
lines to cell-mediated cytotoxicity in vitro, which
help to distinguish between these possibilities. In
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preliminary experiments we have sought and
obtained confirmation of published reports that
NK activity is absent in newborn mice but begins
to become manifest at the age of 3-4 weeks
(Herberman et al., 1975; Kiessling et al., 1979),
whereas quite a high level of NC activity is present
at birth (Stutman et al., 1978).
Materials and methods
Tumours
The origin of, and methods of propagating, the
fibrosarcoma lines have been described previously
(Woodruff & Hodson, 1985). In the present
experiments we have used mainly 4 different clones
(W319, C6 and C12; W324, C17 and C57),
distinguished by their origin from a different
tumour or by a difference in PGK-1 alloenzyme
phenotype. As before, the suffixes C and M
indicate lines maintained in tissue culture and by
serial transplantation respectively; the suffix MC
indicates an M line which was cultured in vitro for
24 or 48h for labelling before an assay was set up.
The murine lymphoma line YAC-1 was used as a
positive control in short-term assays for NK
activity.
Mice
Female CBA/Ca mice were purchased from Bantin
and Kingman Ltd., Hull, England. CBA backcross
nude mice were bred in the Animal Unit at the
Western General Hospital, Edinburgh, in a special
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cabinet supplied with filtered air, from CBA nu/nu
males and CBA nu/+ females obtained from the
Medical Research Council Clinical Research
Centre, Harrow, UK.
Assessment ofsensitivity to cell-mediated
cytotoxicity (CMC) in vitro
Short-term (4h) chromium release assays were used
to assess NK cell cytotoxicity. Long-term (15-18h)
chromium release assay and assays (20-24h) with
cells labelled with [12sI] iododeoxyuridine
(125IUDR) were used to assess NC cell cytotoxicity
and cell-mediated immunity (CMI).
Labelling oftumour cells with 51Cr
Tumour cells, harvested in the usual way with
trypsin and ethylenediaminotetraacetic acid
(EDTA) from cultured lines (C cells) or from
cultures set up 2 days previously with cells from a
mouse (MC cells), were incubated with [51Cr]
sodium chromate (Amersham International,
Amersham, UK), (50yuCi 10-6 cells) for 45 min at
37°C in a shaking water bath, washed twice and re-
suspended in MOPS-buffered Ham's FIO medium
with 10% FCS at 105 viable cells ml-'.
Labelling of tumour cells with 125IUDR
Cultured lines were labelled by replacing the
medium in 75cm2 flasks (or 25cm2 flasks if fewer
cells were required) containing actively growing
cultures with 20ml (or 7ml) medium (Ham's FIO
medium with 10% FCS) containing 10lCi
'25IUDR (or 3pCi) (Amersham International,
Amersham, UK) and 3 pg fluorodeoxyuridine
(FUDR), and continuing incubation for a further
24h at 37°C.
Mouse tumour cells were set up in short-term
cultures by seeding 75cm2 flasks with 8 x 106 cells.
After incubation for 4h at 37°C the medium with
the non-adherent cells was poured off and replaced
by medium containing 10pCi 125IUDR and 3 pg
FUDR. A second dose of 125IUDR (without
FUDR) was added 20h later and incubation was
continued for a further 24h.
The cultures were harvested in the usual way
with trypsin-EDTA, washed twice and re-suspended
in medium with 10% FCS at 1O vaiable cellsml-.
Effector cells
Non-primed effectors Spleen cell suspensions were
prepared by gently disrupting pieces of spleen from
untreated normal (CBA) or nude (CBA nu/nu)
mice, ranging in age from newborn to 12 weeks, in
a hand held glass homogenizer with a loose fitting
plunger. The red cells were lysed by brief (2sec)
exposure to sterile distilled water and the nucleated
cells, which are designated N cells, were counted,
spun down and re-suspended in appropriate
concentrations in medium with 10% FCS.
Effectors from immunized mice Spleen cells were
harvested from 8-10 week old female CBA mice
which had received two i.p. injections of tumour
cells 14 and 4 days previously. Three types of cell
from each of 4 lines were used for immunization:
irradiated (220Gy) mouse cells, irradiated long-
term cultured cells and non-irradiated cultured
cells. The spleen cells from the immunized mice are
designated II, I2 and 13 respectively, preceded by
the designation of the line used for immunization.
The tumour cells were irradiated with a 60Co
source as described previously (Woodruff &
Hodson, 1985).
Removal of adherent cells In some experiments N,
II, I2 and 13 spleen cell suspensions were incubated
in tissue culture flasks for 4h at 37°C. The non-
adherent cells, designated N', I1', I' and F3
respectively, were then harvested, counted in
nigrosin to determine the number of viable cells,
spun down and re-suspended in fresh medium with
10% FCS.
Chromium release assays
The assays were performed in triplicate in flat-
bottomed Falcon II microtest plates (Falcon,
Oxnard, Calif., USA), with 105 tumour cells per
well, and effector:target (E:T) ratios of 100: 1, 50: 1
and 25:1, in a total volume of 200pl MOPS
buffered medium with 10% FCS per well. Medium
control wells contained target cells but no effector
cells in the same total volume as the other wells.
The plates were incubated for either 4h or
between 15 and 18h, the latter time being chosen
because preliminary trials showed virtually no
release of isotope after 8h incubation at 37°C with
targets insensitive to NK cells, and unacceptably
high release with all targets in control wells without
effector cells after 24h. Plates for 4h assays were
centrifuged lightly (20g for 2min in a Serval RT
6000 refrigerated centrifuge) prior to incubation.
After incubation all plates were centrifuged (200g
for 5min) and 100pl of supernatant was removed
for gamma counting, using a removable jig with
perforations corresponding to each well which held
the pipette tip 2mm clear of the well floor.
Maximum release was determined by adding 100p1
of 1% NP 40 detergent to an equal volume of
labelled target cell suspension in Eppendorf tubes,
incubating for 30min, centrifuging and removing
l00pl for counting in a gamma scintillation
spectrometer (LKB, Willac 80000) adjusted for
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The cytotoxic index (CI) was calculated
according to the formula:
c.p.m. in supernatant from wells
with effector cells - c.p.m. in
CI = 100 x supernatant from medium control wells
c.p.m. in maximum release
sample - machine background
1251UDR assays
IUDR assays were performed in triplicate in Falcon
II flat-bottomed microtest plates as used for the
chromium release assays. In preliminary trials
assays based on counting supernatant samples
proved unsatisfactory because significant amounts
of label released from the lysed cells became
attached to the effectors and was lost; the
alternative procedure of washing the wells and
measuring the residual reactivity was therefore
adopted.
The wells were seeded with 100p1 of tumour cell
suspension and the plates were incubated for 4h at
37°C, after which IOOpI of effector cell suspension
of the concentration required to give E:T ratios of
100:1, 50:1 or 25:1, or of medium without cells,
was added. After a further 18-24h incubation the
plates were shaken shaken over a pad of absorbent
material, washed 3 times, dried and sprayed with
Nobecutane (Astra Pharmaceuticals, Watford, UK).
The floor of each well was then punched out with a
steel punch applied to its outer surface, placed in a
polystyrene tube and counted in a gamma
scintillation spectrometer adjusted for 1251.
The cytotoxic index (CI) was calculated
according to the formula:
CI = 100 x
residual c.p.m. in medium control
wells - residual c.p.m. in wells
with effector cells
residual c.p.m. in medium control
wells - machine background
Cell-mediated immunity (CMI) in vitro
As a measure of CMI in vitro we have calculated
the difference between the CI in wells with effectors
from immunized mice and the Cl in wells with the
corresponding normal effectors in the same E:T
ratio. This difference is denoted by ACI.
Results
Sensitivity offibrosarcoma lines in 4h 51Cr assays
The following cloned lines have been tested in 4h
chromium release assays using normal adult CBA
nucleated spleen cells as effectors in E:T ratios of
200:1, 100:1, 50:1 and 25:1: W319C6C, C6M,
CIOC, ClOM, C12C, C12M; W324C17C, C17M,
C57C, C57M. All were completely insensitive, the
CI ranging from 0 to 0.6%, whereas similar assays
with YAC-1 gave positive results with normal adult
CBA spleen cells but, as expected, negative results
with newborn CBA spleen cells. There is, therefore
no evidence that our fibrosarcoma cloned lines are
sensitive to NK cells.
Comparison oflong-term 51Cr (15-18h) and
1251UDR (20-24h) assays
The chromium release assay is simple to perform.
All the targets we have used label readily and the
results are highly reproducible provided that the
counts in the medium control wells are reasonably
low (preferably 1 30% of the maximum release
counts). This was achieved by running the assays
for 15-18h.
The IUDR assay gives reproducible results
provided that the target cells label satisfactorily and
that a high proportion of those labelled remain
attached in the medium control wells. As the result
of preliminary experiments we have developed a
technique which is satisfactory with actively
growing cultured line targets, and with 2 of the 4
mouse lines tested (319C6M and 324C17M) but not
with the other two (319C12M and 324C57M). This
difference reflects the relative slowness of the latter
two clones to adapt to growth in vitro. When
applicable, the IUDR assay gives higher values for
the CI than the chromium release assays, but this
difference is due partly to the difference in the
denominators of the fractions used to calculate the
CI in the two assays.
Sensitivity offibrosarcoma lines in long-term 51Cr
and 125IUDR assays
Assays with untreated normal adult spleen cells as
effectors The results are summarised in Table I.
Although the replicates in each assay showed little
variation, the results of assays performed on
different days with effectors from different mice
differed considerably. The reason for this is not
clear. The age of the spleen cell donors ranged from
8-12 weeks but within these limits we have not
observed any correlation between the age of the
spleen donor and the CI obtained with a variety of
targets.
Despite this variation between assays performed
at different times, it is possible to compare the
results obtained on the same day with the same
effectors acting on different targets. Since 51Cr and
125IUDR assays performed at the same time with
the same effectors and the same cell lines as targets,236 M.F.A. WOODRUFF & B.A. HODSON
Table I Long-term assays with normal adult spleen cells as effectors
Target E: T
cells ratio CI 5ICr release assays CI in 125IUDR assays
319C6C 100 17.4 7.2 32.4 8.5 38.5 20.2 27.0 15.7 31.8 20.3
50 9.7 4.4 18.1 4.5 25.6 13.1 31.3 8.6 28.1 12.3
25 5.8 2.6 10.7 3.1 13.2 9.0 26.0 4.4 22.2 9.4
319C6MC 100 3.6 .0.9 11.8 0 7.5 2.1 7.4 26.5 18.8 18.4
50 1.3 1.0 3.6 0 5.0 0 34.0 7.4 17.5 13.1
25 0 0 2.3 1.5 4.0 0 14.7 2.9 7.1 14.6
319C12C 100 3.4 0.1 3.7 0.5 2.7 0 5.7 4.3 3.8
50 2.4 0.2 0.8 0 1.8 0 0 0 8.2
25 2.7 0.8 0 0 0 11.8 0 4.1 5.7
319C12MC 100 1.4 0 6.7 0 0.4
50 0 0 1.1 0 0
25 3.8 0 0 0 0
324C17C 100 12.6 4.4 0 0.4
50 0.7 1.5 0 0
25 1.4 1.0 0 0
324C17MC 100 0 0 0 10.2
50 0 0 0 1.2
25 0 0 0 2.4
324C57C 100 5.7 0 0 0
50 3.3 0 0 0
25 2.2 0 0 0
324C57MC 100 0.5 2.5
50 0.8 0
25 0 0.3
The figures in the same column relate to the same assay except where the column is
interrupted by a horizontal line.
The assay in the first of the 5'Cr columns was performed at the same time as the assay
in the first ofthe '25IUDR columns and so on.
and observations in the same assay at different E:T
ratios, cannot be regarded as independent, the
safest procedure is to regard the whole array of CI
value generated by simultaneous 51Cr and (when
performed) 125IUDR assays with a given target and
type of effector as constituting a single experimental
result. The individual values might be combined in
various ways to give numerical expression to this
result, but when, as is fortunately the case in Table I,
the individual values in any one array are nearly
always consistently less or consistently greater
than the corresponding values in every other array,
it is not necessary to specify precisely how this
should be done.
It appears from these assays that W319C6C is
moderately sensitive to NC cells whereas
W319C12C, W324C17C and W324C57C are, at
most, only slightly sensitive. It can also be
concluded that 319C6M, though not completely
insentivive, is less sensitive than 319C6C, since in
each of the six independent pairs of arrays available
for comparison the values of the CI for 319C6M
are less than those for 319C6C, and the probability
of this occurring as an error of random sampling is
(1/2)6 i.e. 0.016. It looks also as if 324C17M may
be less sensitive than 324C17C, but this cannot be
asserted with confidence.
Effect of removing adherent spleen cells Removing
adherent cells from the spleen cell population made
no appreciable difference to the values obtained for
the CI in both 5"Cr and I26IUDR assays for NC
cell activity (Table II).
Effect of a single passage in newborn and nude mice
or sensitivity oftumours to NC cells
As a preliminary to these experiments we have
confirmed the observation of Stutman et al. (1981)
that spleen cells from newborn normal mice exhibit
NC cell activity, although in our assay the CI with
newborn CBA spleen cells against 319C6C target
cells was only about half that of adult spleen cells.
Spleen cells from newborn nu/nu mice (shown to be
athymic at autopsy) were also cytotoxic though in
our assay the CI with these cells at an E:T ratio of
100:1 was only about one third that obtained with
normal adult spleen cells.SENSITIVITY OF MURINE SARCOMAS TO CMC 237
Table II Long-term assays with spleen cells from normal mice. Effect of removing adherent
cells.
CIfor target and type ofassay
Treatment E:T 319C6C 319C6MC 319C12C 319C12MC
ofeffectors ratio 51Cr 125IUDR 51Cr "1Cr 125IUDR 51Cr
No treatment 100 7.9 18.0 0.5 0 1.9 0
(N cells) 50 4.5 10.5 0.5 0.1 4.1 0
25 2.9 6.9 0.7 0.7 3.7 0
Removal of 100 5.1 14.1 0 0 0 0
adherent cells 50 1.1 15.0 0 0 2.0 2.0
(N' cells) 25 1.4 5.4 0 0 4.0 0.7
Table III Effect of a single passage in newborn and nude mice on
sensitivity of tumours to NC cells
Tumour CI in 5lCr CI in
and Host in which E:T release 1251UDR
clone passaged ratio assays assays
319C6 Not passaged 100 32.4 17.4 31.8 27.0
50 18.1 9.7 28.1 31.3
25 10.7 5.8 22.2 26.0
Adult nude 100 11.8 7.8
50 3.6 0
25 2.3 0
Newborn normal 100 3.0 30.0
50 1.2 21.1
25 0 14.3
Newborn nude 100 10.6 8.7 18.4 33.9
50 4.5 5.2 2.9 23.0
25 2.6 1.9 0.1 14.7
324C17 Not passaged 100 4.4 0.4
50 1.5 0
25 1.0 0
Adult normal 100 0 0
50 0 0
25 0 0
Newborn normal 100 0 0 0
50 0 0 0
25 0 0 0
Newborn nude 100 0 0 0
50 0 0 0
25 0 0 0
The figures in the same column related to the same assay except where
the column is interrupted by a horizontal line. The assay in the first
of the " Cr columns was performed at the same time as the assay in the
first of the '25IUDR columns, and similarly for the second columns for
each isotope.
Our observations on the sensitivity of passaged
cells to the cytotoxic effect of normal adult spleen
cells are summarised in Table III. In both
chromium assays and one iodine assay W319C6
appears to have become less sensitive, but not
completely insensitive, after passage in all the types
of host listed. W324C17 was completely insensitive
after passage in all the assays but the unpassaged
cultured line is itself, at most, only very slightly
sensitive.238 M.F.A. WOODRUFF & B.A. HODSON
Table IV Long-term assays with immunized effectors. W319 targets
Value ofACIfor the target shown
Category 319C6C 319C6MC 319C12C 319C12MC
of E:T SCr 125IUDR 51Cr 125IUDR 51Cr 125IUDR 51Cr
effectora ratio assay assay assay assay assay assay assay
C611 100 0 5.8 3.0 25.0 0 3.3 0
50
25
C61' 100
50
25
C6I2 100
50
25
C61'2 100
50
25
C6I3 100
50
25
C6I3 100
50
25
C121, 100
50
25
C121' 100
50
25
C1212 100
50
25
C121'2 100
50
25
C1213 100
50
25
C12I'3 100
50
25
1.6
0.4
3.7
9.2
3.3
4.8
0.4
0
2.7
2.8
1.7
0
1.9
3.6
6.9
3.8
0.4
0
0
0
0.5
0
3.8
0.4
1.0
1.1
6.3
14.4
1.0
1.3
6.3
0
1.3
25.5
3.6
0.7
43.9
18.9
0
0
0
0
0
0.6
0
0
0
0
0
2.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20.2
18.2
15.0
13.7
13.8
27.5
22.4
9.7
19.3
12.8
19.1
14.1
15.0
11.5
18.4
18.9
10.6
26.2
17.1
5.3
13.4
2.3
1.9
0
0
1.2
0
8.7
4.2
2.7
9.9
5.1
2.3
9.9
2.4
0
9.3
6.6
2.3
16.7
5.5
3.9
27.8
34.0
5.3
0
0
0
3.1
40.1
24.7
12.5
39.0
18.9
11.2
38.0
22.5
6.0
33.8
13.1
4.5
60.2
29.8
12.6
63.0
34.0
'See text for definition of the various categories ofeffectors.
ACI=CI for immunised effectors - CI for the corresponding normal effectors.
Assaysfor cell-mediated immunity (CMI) in vitro
The result of assays with spleen cells from
immunized donors are summarised in Tables IV
and V. The various categories of effector cell (I1,
I1, 2,912 etc.), and the meaning of ACI, are defined
under Materials and methods.
The IUDR assay, where applicable, appear to be
distinctly more sensitive than the chromium release
assays for detecting CMI in vitro.
Immunization with the same clone as the target
W319C12 appears to be more sensitive to CMI
than W319C6 (i.e. the opposite of what was found
with NC cells); W324C17 is possibly slightly more
sensitive than W324C57. For each clone there are
no systematic differences in sensitivity between the
cultured and mouse-passaged lines. There are also
no systematic differences in cytotoxicity between
spleen cells immunized with irradiated mouse-
passaged cells (I,), irradiated cultured cells (I2) and
viable cultured cells (13). Removing adherent cells
from the effector population did not significantly
affect the results with any of the targets tested.
Cross immunization In general, spleen cells from
donors immunized with a different clone to the
0
0
0
0
0
4.5
0
2.7
5.6
0.4
0
2.6
2.3
0
4.8
0
0
7.7
3.4
0
13.7
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Table V Long-term 51Cr release with immunized effectors. W324 targets.
Value ofACIfor target shown
Category of E:T
effector ratio 324C17C 324C17M 324C57C 324C57M
C171, 100 10.3 7.8 0.6 1.7
50 19.0 6.1 0 3.2
25 2.4 6.1
C171'1 100 5.6 13.2 0 2.0
50 7.6 5.3 0 3.6
25
C17M2 100 4.8 3.1 3.9 1.7
50 10.2 3.0 0 3.0
25 0.4 0.7
C17I3 100 4.0 7.8 2.7 4.9
50 10.1 0 3.8 8.4
25 5.3 0
C571, 100 1.4 4.0 0 1.6
50 4.6 2.3 0.5 3.8
25 0 0
C571' 100 0 0 1.3 6.2
50 3.4 0 0.2 5.2
25
C57I2 100 7.8 7.8 9.6 8.7
50 14.6 5.6 2.0 6.9
25 0 0
C57I3 100 5.2 5.0 0.6 2.0
50 9.1 8.8 0 3.7
25 0 0
See footnote to Table IV regarding the various categories ofeffectors and the
definition ofACI.
target tested were either no more cytotoxic, or only
slightly more cytotoxic, than normal spleen cells.
An exception to this rule is the sensitivity in the
IUDR assay, but not the chromium release assay,
of 319C6M cells to spleen cells from mice
immunized with C12M.
Discussion
The primary object of the present experiments was
to test the hypothesis that when cultured cloned
murine fibrosarcoma lines are passaged in
immunodeficient mice they acquire the capacity to
grow in normal isogenic hosts because, during the
initial passage, they beome resistant to attack by
NK or NC cells, and this postulated resistance just
sufficies to tip the balance in the favour when they
encounter combined attack by NK/NC cells and
cytotoxic T cells in the normal host.
It now seems clear that this hypothesis is false so
far as NK cells are concerned because with all the
clones tested even the cultured lines are NK cell
resistant. Acquisition of resistance to NC cells, on
the other hand, may play a role with some clones,
e.g. W319C6. In the present experiments the
cultured line of this clone was moderately NC cell
sensitive and became less so on passage, and this
accords with our previous finding (Woodruff &
Hodson, 1985) that after s.c. injection of viable
'25I-labelled cells to non-immunized mice, the rate
of loss of label from day 1 to day 5 was greater
with C6C than with C6MC. This will not serve as a
general explanation however because 3 of the 4
cultured lines tested in vitro showed at most only
slight sensitivity to NC cells. Moreover, we have
shown recently with one other clone (W324C17)
that insensitivity in vitro is associated with insensi-
tivity in vivo as indicated by the slow early (day 1-
day 5) loss of label after s.c. injection of 12511
labelled cells (Woodruff & Hodson, unpublished).
A subsidiary objective was to determine whether
the conclusion drawn from our previous in vivo
experiments (Woodruff & Hodson, 1985) that
cultured and mouse-passaged lines of the same
clone differ little, if at all, in their capacity to evoke
an immune reaction, holds good also when the
magnitude of the reaction is assessed by in vitro
assays. It now seems clear that this is the case.
Of the three hypotheses proposed in our previous240 M.F.A. WOODRUFF & B.A. HODSON
paper to account for the effect of passage in
immunodeficient mice, two remain: the acquisition
of a protective surface molecule, and the loss or
modification of a Class I MHC molecule necessary
for recognition by T cells. The fact that passaged
tumour cells remain immunogenic tells against the
latter possibility, but it is conceivable that the
immunogenic stimulus might be provided by host T
cells which have acquired TATA from the tumour
and present these, in association with their own
Class I MHC molecules, to other T cells.
Experiments designed to explore these and other
possibilities will be reported in a subsequent paper.
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